Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Borer

Showing results (11-20 of 394) with videos related to

Pageof 40
Sort By:
Journal of Clinical Pharmacology|December 1, 1991
Regurgitant valvular diseaseJ S Borer
Cardiology|December 14, 2012
Statement on matching language to the type of evidence used in describing outcomes dataJeffrey S Borer,
Seminars in Thoracic and Cardiovascular Surgery|April 1, 1990
Determinants of prognosis in heart failure and timing of operationJ S Borer
Arteriosclerosis, Thrombosis, and Vascular Biology|February 26, 2005
Aortic stenosis and statins: more evidence of "pleotropy"?Jeffrey S Borer
Delaware Medical Journal|April 7, 2011
Drug Utilization Review Board, Delaware MedicaidMark S Borer
American Journal of Therapeutics|May 1, 1995
The Fourth International Symposium on Cardiovascular Drug Development: Developing Drugs for Ischemic Heart Disease---IntroductionJerry S. Borer
Journal of the American College of Cardiology|April 20, 2019
Application of Transcatheter Repair to Tricuspid Regurgitation: Still Looking Through a Dark GlassJeffrey S Borer
Journal of Clinical Pharmacology|September 1, 1992
Advances in Cardiovascular Pharmacology: Protocol Design and Methodology. Proceedings of the 11th annual symposium. Atherosclerosis and Drug Development for Ischemic Heart DiseaseJ S Borer
Journal of the American College of Cardiology|December 21, 2004
Development of cardiovascular drugs: the U.S. regulatory milieu from the perspective of a participating nonregulatorJeffrey S Borer
Nature Clinical Practice. Cardiovascular Medicine|November 3, 2005
Drug insight: If inhibitors as specific heart-rate-reducing agentsJeffrey S Borer
Pageof 40

Showing results (11-20 of 394) with videos related to

Sort By:
Pageof 40
Journal of Clinical Pharmacology|December 1, 1991
Regurgitant valvular diseaseJ S Borer
Cardiology|December 14, 2012
Statement on matching language to the type of evidence used in describing outcomes dataJeffrey S Borer,
Seminars in Thoracic and Cardiovascular Surgery|April 1, 1990
Determinants of prognosis in heart failure and timing of operationJ S Borer
Arteriosclerosis, Thrombosis, and Vascular Biology|February 26, 2005
Aortic stenosis and statins: more evidence of "pleotropy"?Jeffrey S Borer
Delaware Medical Journal|April 7, 2011
Drug Utilization Review Board, Delaware MedicaidMark S Borer
American Journal of Therapeutics|May 1, 1995
The Fourth International Symposium on Cardiovascular Drug Development: Developing Drugs for Ischemic Heart Disease---IntroductionJerry S. Borer
Journal of the American College of Cardiology|April 20, 2019
Application of Transcatheter Repair to Tricuspid Regurgitation: Still Looking Through a Dark GlassJeffrey S Borer
Journal of Clinical Pharmacology|September 1, 1992
Advances in Cardiovascular Pharmacology: Protocol Design and Methodology. Proceedings of the 11th annual symposium. Atherosclerosis and Drug Development for Ischemic Heart DiseaseJ S Borer
Journal of the American College of Cardiology|December 21, 2004
Development of cardiovascular drugs: the U.S. regulatory milieu from the perspective of a participating nonregulatorJeffrey S Borer
Nature Clinical Practice. Cardiovascular Medicine|November 3, 2005
Drug insight: If inhibitors as specific heart-rate-reducing agentsJeffrey S Borer
Pageof 40